Pneumococcal vaccinationdoi:10.1016/S0140-6736(81)91873-0P.Helena MäkeläThe LancetIndications for pneumococcal vaccine, editorial. Lancet 1981; 1:251-253.Editorial, Indications for pneumococcal vaccine, Lancet i , 251 (1981).
pneumoniae for individuals meeting criteria for immunization outside of pregnancy. Pneumococcal vaccine uptake has been low. There are no data available for vaccine uptake in pregnancy, but we suspect it is lower than non-pregnant populations. Low uptake of immunization rates in pregnancy is likely ...
However, several indications have been added to the pneumococcal polysaccharide vaccine footnote, clarifications have been made to the footnotes for human ... CB Bridges,L Woods,T Coyne-Beasley - 《Annals of Internal Medicine》 被引量: 4发表: 2009年 THE IMPACT OF EARLY VERSUS LATE INITIATION OF...
pneumococcal vaccine 13-valent pneumococcal vaccine heptavalent pneumococcal vaccine polyvalent quinidine rabies vaccine rabies vaccine chick embryo cell derived ranolazine rifabutin rifampin rotavirus oral vaccine, live rubella vaccine silodosin sirolimus smallpox (vaccinia) vaccine, live sotorasib squill St ...
pneumococcal vaccine heptavalent pneumococcal vaccine polyvalent poliovirus vaccine inactivated prasugrel protein C concentrate rabies vaccine rabies vaccine chick embryo cell derived ribociclib rivaroxaban rucaparib schisandra sertraline siponimod stiripentol sulindac talazoparib tazemetostat tecovirimat tenecteplase...
This is an open-label phase 2 study of elranatamab in combination with isatuximab administered subcutaneously in patients with relapsed and refractory multiple myeloma (RRMM) who have received at least two prior lines of therapy and who have had previous treatment with both immunomodulatory drugs ...
Indications for Pneumococcal Vaccinedoi:10.1016/S0140-6736(81)92090-0NoneLancetEditorial, Indications for pneumococcal vaccine, Lancet i , 251 (1981).Indications for pneumococcal vaccine, editorial. Lancet 1981; 1:251-253.
Persons with certain underlying conditions are at increased risk of hospitalization or death associated with pneumococcal infection. The pneumococcal polysaccharide vaccine (PPV) is recommended for persons aged 65 years and 2-64 years with high-risk conditions.P. Lu...
vaccineObjective - The authors had for aim to evaluate the effectiveness and clinical indications of the anti pneumococcal vaccine. Methods - Seventy one articles were selected after a computerized research including the most recent studies on immunogenicity, all the prospective double blind randomized ...
However, several indications have been added to the pneumococcal polysaccharide vaccine footnote, clarifications have been made to the footnotes for human ... CB Bridges,L Woods,T Coyne-Beasley - 《Annals of Internal Medicine》 被引量: 4发表: 2009年 THE IMPACT OF EARLY VERSUS LATE INITIATION OF...